STEM CELL THERAPY FOR COMMUNITY ACQUIRED PNEUMONIA INDUCED SEPSIS

SEPCELL at the EU-MSC2 Meeting | September 12-13 2017, Leiden, The Netherlands

The SEPCELL Consortium was invited to join the EU-MSC2 meeting in Leiden, The Netherlands. EU-MSC2 is a scientific meeting gathering EU funded consortia working on immune modulation using Mesenchymal Stromal Cells (EU-MSC2).  Nine EU financed research consortia gathered at this event to further the knowledge on MSC research.

Dr. Olga de la Rosa, Scientific Director at TiGenix, presented the SEPCELL Consortium, the challenges faced and the progress on the trial.

Sepcell

We use [own and third parties] cookies to analyse the use of our website and improve our services. If you continue visiting the website you are agreeing our cookies policy. You can change the configuration of the cookies and obtain additional information.

MORE INFO